Regeneron Pharmaceuticals
REGN
#380
Rank
ยฃ49.96 B
Marketcap
ยฃ476.55
Share price
-0.17%
Change (1 day)
24.82%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2026 (TTM): ยฃ3.82 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are ยฃ14.91 Billion. In 2025 the company made an earning of ยฃ3.94 Billion, an increase over its 2024 earnings that were of ยฃ3.60 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) ยฃ3.82 B-3.17%
2025 ยฃ3.94 B9.43%
2024 ยฃ3.60 B13.83%
2023 ยฃ3.16 B-13.57%
2022 ยฃ3.66 B-47.9%
2021 ยฃ7.03 B144.75%
2020 ยฃ2.87 B56.86%
2019 ยฃ1.83 B-4.87%
2018 ยฃ1.92 B22.86%
2017 ยฃ1.56 B56.3%
2016 ยฃ1.00 B8.55%
2015 ยฃ0.92 B54.53%
2014 ยฃ0.59 B11.14%
2013 ยฃ0.53 B72.13%
2012 ยฃ0.31 B-285.93%
2011 -ยฃ0.17 Billion121.73%
2010 -ยฃ75.83 Million37.18%
2009 -ยฃ55.28 Million-14.6%
2008 -ยฃ64.73 Million-25.02%
2007 -ยฃ86.33 Million6.32%
2006 -ยฃ81.2 Million-186.52%
2005 ยฃ93.84 M2103.7%
2004 ยฃ4.25 M-105.66%
2003 -ยฃ75.26 Million-18.18%
2002 -ยฃ91.99 Million42.33%
2001 -ยฃ64.63 Million129.35%
2000 -ยฃ28.18 Million51.87%
1999 -ยฃ18.56 Million92.19%
1998 -ยฃ9.66 Million66.23%
1997 -ยฃ5.81 Million-55.49%
1996 -ยฃ13.05 Million103.53%
1995 -ยฃ6.42 Million-70.89%
1994 -ยฃ22.03 Million-26.08%
1993 -ยฃ29.8 Million114.67%
1992 -ยฃ13.88 Million196.77%
1991 -ยฃ4.68 Million87.88%
1990 -ยฃ2.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.59 B 403.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ11.90 B 206.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
ยฃ6.85 B 76.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ5.77 B 48.51%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
ยฃ1.22 B-68.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ0.65 B-83.14%๐Ÿ‡บ๐Ÿ‡ธ USA